NCT06736418
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06736418
Title Study of 225Ac-ABD147 to Establish Optimal Dose in Patients with SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Abdera Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
University of California, Los Angeles Santa Monica California 90404 United States Details
Mayo Clinic - Jacksonville Jacksonville Florida 32224 United States Details
Sylvester Comprehensive Cancer Center, Univ of Miami Miami Florida 33136 United States Details
Florida Cancer Specialists - Sarasota Sarasota Florida 34232 United States Details
United Theranostics Glen Burnie Maryland 21061 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
MD Anderson Houston Texas 77030 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field